The analysis of disabilities is split into 7 parts that can be read independently but are related and complement each other. Each section is written in a different web page within which at the top the user can find the links to navigate to the other sections. The 7 parts are:
Part 1 - Overview of the Data.
Go to Part 1
This part provides the overall description of the data and shows the historical time series of disability rates for different population cohorts and age groups. It allows us to put in perspective the changes in disability rates, that started in 2021.
Part 2 - Rise in disabilities from 2021.
Go to Part 2
This part provides a detailed examination of the changes in disabilities that ocurred from early 2021, which coincided with the vaccine rollouts.
Part 3 - Relationship with Vaccine uptake.
Go to Part 3
This part analyses the relationship between the rise in disabilities with the Covid-19 vaccine rollout.
Part 4 - Relationship with Excess Deaths.
Go to Part 4
This part investigates the relationship between excess mortality and the rise in disabilities that ocurred since early 2021. It also provides us with an estimate of how many disabilities occurred for each excess death, during the period.
Part 5 - Relationship with SAEs in mRNA clinical trials
Go to Part 5
This part investigates the relationship between Serious Adverse Events (SAEs) from the mRNA clinical trials with the rise in disabilities that ocurred since early 2021.
Part 6 - Relationship with Severe AEs in Pfizer vaccine clinical trial
Go to Part 6
This part investigates the relationship between Adverse Events (AEs) and Severe Adverse Events (Sev AEs) from the Pfizer clinical trial with the rise in disabilities that ocurred since early 2021.
Part 7 - Relationship with Hospitalisations following vaccination reported in V-Safe
Go to Part 7
This part investigates the relationship between hospitalisation events obtained from the V-Safe app with the rise in disabilities that ocurred since early 2021. It also compares the time series of hospitalisation events with the time series of Adverse Events (AEs) and Severe Adverse Events (Sev AEs) from the Pfizer clinical trial.
PHINANCE TECHNOLOGIES
Download project brief (pdf)